Barry Fishman

Barry Fishman is Managing Director at Sequoia Advisors, Inc. since 2014.
Mr. Fishman is Independent Director at Field Trip Health & Wellness Ltd., Medicus Pharma Ltd. since 2023, and Apotex, Inc. Mr. Fishman is Director & Head-Pharmaceuticals at Algae-C, Inc. Mr. Fishman is Chief Corporate Development Officer at Apotex Health Corp.
Former roles include Chief Executive Officer at Norgine BV; Chief Executive Officer at Teva Canada Ltd. from 2003 to 2013; Chief Executive Officer at Merus Labs International, Inc. in 2017; Chief Executive Officer at Taro Pharmaceuticals, Inc. from 2000 to 2003; Chief Executive Officer & Director at VIVO Cannabis, Inc. from 2017 to 2020; Chairman at The Canadian Generic Pharmaceutical Association; Independent Director at Aurora Cannabis, Inc. from 2016 to 2017; Independent Director at Advanz Pharma Corp.
Ltd. from 2018 to 2020; Independent Director at Canopy Growth Corp.
from 2014 to 2016; Independent Director at Bedrocan Cannabis Corp.; Independent Director at Akerna Corp.
from 2021 to 2023; Director at Juno Pharmaceuticals Corp.; Lead Director at Field Trip Health Ltd.; Lead Independent Director at Reunion Neuroscience, Inc.; Vice President-Marketing at Eli Lilly Canada, Inc. from 1983 to 2000; Senior Associate at Deloitte Development LLC from 1979 to 1982.
Education includes undergraduate degree from McGill University.